vs
Side-by-side financial comparison of ADAMAS TRUST, INC. (ADAM) and MEDIFAST INC (MED). Click either name above to swap in a different company.
MEDIFAST INC is the larger business by last-quarter revenue ($75.1M vs $43.2M, roughly 1.7× ADAMAS TRUST, INC.). On growth, ADAMAS TRUST, INC. posted the faster year-over-year revenue change (61.6% vs -36.9%). ADAMAS TRUST, INC. produced more free cash flow last quarter ($125.9M vs $-6.6M). Over the past eight quarters, ADAMAS TRUST, INC.'s revenue compounded faster (55.5% CAGR vs -34.4%).
Medifast, Inc. is an American nutrition and weight loss company based in Baltimore, Maryland. Medifast produces, distributes, and sells weight loss and health-related products through websites, multi-level marketing, telemarketing, and franchised weight loss clinics.
ADAM vs MED — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $43.2M | $75.1M |
| Net Profit | $53.5M | — |
| Gross Margin | — | 69.4% |
| Operating Margin | — | -10.4% |
| Net Margin | 124.0% | — |
| Revenue YoY | 61.6% | -36.9% |
| Net Profit YoY | 270.5% | — |
| EPS (diluted) | $0.45 | $-1.64 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $43.2M | $75.1M | ||
| Q3 25 | $36.6M | $89.4M | ||
| Q2 25 | $36.4M | $105.6M | ||
| Q1 25 | $33.1M | $115.7M | ||
| Q4 24 | $26.7M | $119.0M | ||
| Q3 24 | $20.2M | $140.2M | ||
| Q2 24 | $19.0M | $168.6M | ||
| Q1 24 | $17.9M | $174.7M |
| Q4 25 | $53.5M | — | ||
| Q3 25 | $44.8M | $-2.3M | ||
| Q2 25 | $8.5M | $2.5M | ||
| Q1 25 | $42.2M | $-772.0K | ||
| Q4 24 | $-31.4M | — | ||
| Q3 24 | $42.8M | $1.1M | ||
| Q2 24 | $-15.6M | $-8.2M | ||
| Q1 24 | $-57.9M | $8.3M |
| Q4 25 | — | 69.4% | ||
| Q3 25 | — | 69.5% | ||
| Q2 25 | — | 72.6% | ||
| Q1 25 | — | 72.8% | ||
| Q4 24 | — | 74.1% | ||
| Q3 24 | — | 75.4% | ||
| Q2 24 | — | 73.2% | ||
| Q1 24 | — | 72.8% |
| Q4 25 | — | -10.4% | ||
| Q3 25 | — | -4.6% | ||
| Q2 25 | 11.7% | -1.0% | ||
| Q1 25 | — | -1.1% | ||
| Q4 24 | -119.0% | 0.6% | ||
| Q3 24 | — | 1.5% | ||
| Q2 24 | -124.7% | -4.7% | ||
| Q1 24 | -448.8% | 4.5% |
| Q4 25 | 124.0% | — | ||
| Q3 25 | 122.5% | -2.5% | ||
| Q2 25 | 23.4% | 2.3% | ||
| Q1 25 | 127.4% | -0.7% | ||
| Q4 24 | -117.5% | — | ||
| Q3 24 | 211.7% | 0.8% | ||
| Q2 24 | -81.9% | -4.8% | ||
| Q1 24 | -324.1% | 4.8% |
| Q4 25 | $0.45 | $-1.64 | ||
| Q3 25 | $0.36 | $-0.21 | ||
| Q2 25 | $-0.04 | $0.22 | ||
| Q1 25 | $0.33 | $-0.07 | ||
| Q4 24 | $-0.46 | $0.08 | ||
| Q3 24 | $0.36 | $0.10 | ||
| Q2 24 | $-0.29 | $-0.75 | ||
| Q1 24 | $-0.75 | $0.76 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $210.3M | $167.3M |
| Total DebtLower is stronger | $735.8M | — |
| Stockholders' EquityBook value | $1.4B | $198.9M |
| Total Assets | $12.6B | $248.0M |
| Debt / EquityLower = less leverage | 0.52× | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $210.3M | $167.3M | ||
| Q3 25 | $185.3M | $173.5M | ||
| Q2 25 | $160.4M | $162.7M | ||
| Q1 25 | $177.1M | $164.6M | ||
| Q4 24 | $167.4M | $162.3M | ||
| Q3 24 | $195.1M | $170.0M | ||
| Q2 24 | $235.5M | $163.5M | ||
| Q1 24 | $226.9M | $156.4M |
| Q4 25 | $735.8M | — | ||
| Q3 25 | $766.6M | — | ||
| Q2 25 | $653.0M | — | ||
| Q1 25 | $654.4M | — | ||
| Q4 24 | $573.2M | — | ||
| Q3 24 | $699.4M | — | ||
| Q2 24 | $800.7M | — | ||
| Q1 24 | $1.0B | — |
| Q4 25 | $1.4B | $198.9M | ||
| Q3 25 | $1.4B | $214.7M | ||
| Q2 25 | $1.4B | $216.0M | ||
| Q1 25 | $1.4B | $211.0M | ||
| Q4 24 | $1.4B | $210.1M | ||
| Q3 24 | $1.4B | $207.3M | ||
| Q2 24 | $1.4B | $205.3M | ||
| Q1 24 | $1.5B | $211.0M |
| Q4 25 | $12.6B | $248.0M | ||
| Q3 25 | $12.4B | $268.2M | ||
| Q2 25 | $10.6B | $269.3M | ||
| Q1 25 | $10.0B | $280.0M | ||
| Q4 24 | $9.2B | $284.2M | ||
| Q3 24 | $8.9B | $291.2M | ||
| Q2 24 | $8.2B | $293.5M | ||
| Q1 24 | $7.4B | $302.8M |
| Q4 25 | 0.52× | — | ||
| Q3 25 | 0.55× | — | ||
| Q2 25 | 0.47× | — | ||
| Q1 25 | 0.47× | — | ||
| Q4 24 | 0.41× | — | ||
| Q3 24 | 0.48× | — | ||
| Q2 24 | 0.56× | — | ||
| Q1 24 | 0.67× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $134.0M | $-5.3M |
| Free Cash FlowOCF − Capex | $125.9M | $-6.6M |
| FCF MarginFCF / Revenue | 291.6% | -8.8% |
| Capex IntensityCapex / Revenue | 18.9% | 1.8% |
| Cash ConversionOCF / Net Profit | 2.50× | — |
| TTM Free Cash FlowTrailing 4 quarters | — | $1.2M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $134.0M | $-5.3M | ||
| Q3 25 | $6.9M | $12.1M | ||
| Q2 25 | $39.2M | $-3.4M | ||
| Q1 25 | $25.8M | $3.4M | ||
| Q4 24 | $14.1M | $-4.9M | ||
| Q3 24 | $-922.0K | $9.1M | ||
| Q2 24 | $-993.0K | $13.1M | ||
| Q1 24 | $-13.1M | $7.3M |
| Q4 25 | $125.9M | $-6.6M | ||
| Q3 25 | — | $10.8M | ||
| Q2 25 | — | $-4.8M | ||
| Q1 25 | — | $1.9M | ||
| Q4 24 | $-10.6M | $-7.2M | ||
| Q3 24 | $-8.6M | $7.7M | ||
| Q2 24 | $-8.6M | $11.1M | ||
| Q1 24 | $-19.1M | $5.4M |
| Q4 25 | 291.6% | -8.8% | ||
| Q3 25 | — | 12.0% | ||
| Q2 25 | — | -4.5% | ||
| Q1 25 | — | 1.6% | ||
| Q4 24 | -39.6% | -6.1% | ||
| Q3 24 | -42.3% | 5.5% | ||
| Q2 24 | -44.9% | 6.6% | ||
| Q1 24 | -107.0% | 3.1% |
| Q4 25 | 18.9% | 1.8% | ||
| Q3 25 | — | 1.5% | ||
| Q2 25 | — | 1.3% | ||
| Q1 25 | — | 1.3% | ||
| Q4 24 | 92.3% | 1.9% | ||
| Q3 24 | 37.7% | 1.0% | ||
| Q2 24 | 39.7% | 1.1% | ||
| Q1 24 | 33.5% | 1.1% |
| Q4 25 | 2.50× | — | ||
| Q3 25 | 0.15× | — | ||
| Q2 25 | 4.59× | -1.36× | ||
| Q1 25 | 0.61× | — | ||
| Q4 24 | — | — | ||
| Q3 24 | -0.02× | 8.04× | ||
| Q2 24 | — | — | ||
| Q1 24 | — | 0.88× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
ADAM
| Other | $19.6M | 45% |
| Constructive Loans LLC | $14.4M | 33% |
| Multifamily | $9.1M | 21% |
MED
Segment breakdown not available.
